Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
BioMarin doses first patient in global GENEr8-1 Phase 3 study
December 20, 2017 Off

BioMarin doses first patient in global GENEr8-1 Phase 3 study

By Dino Mustafić

BioMarin Pharmaceutical has dosed the first patient in the global GENEr8-1 Phase 3 study with the 6e13 vg/kg dose for…

Shire receives FDA clearance for myPKFiT
December 19, 2017 Off

Shire receives FDA clearance for myPKFiT

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Shire’s myPKFiT for ADVATE, a free web-based…

Pfenex cashes $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals
December 19, 2017 Off

Pfenex cashes $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals

By Dino Mustafić

Pfenex has announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and…

Hikma nets deal with Celltrion for third biosimilar product in the MENA
December 19, 2017 Off

Hikma nets deal with Celltrion for third biosimilar product in the MENA

By Dino Mustafić

Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc (Celltrion) for the first…

Sanofi and Alnylam apply to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
December 18, 2017 Off

Sanofi and Alnylam apply to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis

By Dino Mustafić

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the RNAi therapeutics company,…

Allergan promotes new Executive Vice President, Global Operations
December 18, 2017 Off

Allergan promotes new Executive Vice President, Global Operations

By Dino Mustafić

Allergan has announced that Wayne Swanton has been promoted to Executive Vice President, Global Operations following notification that Rob Stewart,…

BMS gets positive CHMP opinion for approval of Yervoy for children with unresectable or metastatic melanoma
December 18, 2017 Off

BMS gets positive CHMP opinion for approval of Yervoy for children with unresectable or metastatic melanoma

By Dino Mustafić

Bristol-Myers Squibb Company (NYSE:BMY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…

US FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
December 18, 2017 Off

US FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer

By Dino Mustafić

The US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of AstraZeneca’s…

Horizon Discovery enters into agreement with Roche Diagnostics
December 18, 2017 Off

Horizon Discovery enters into agreement with Roche Diagnostics

By Dino Mustafić

Horizon Discovery Group has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays.

Teva swings huge axe, suspends dividend, no bonuses. Tough year for Israeli drugmaker
December 18, 2017 Off

Teva swings huge axe, suspends dividend, no bonuses. Tough year for Israeli drugmaker

By Dino Mustafić

According to the press release from Thursday, Teva said it needs to reduce total cost base by $3 billion by the end…

Posts pagination

Previous 1 … 3,419 3,420 3,421 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine